MicroRNA-195 inhibits colorectal cancer cell proliferation, colony-formation and invasion through targeting CARMA3

Molecular Medicine Reports

Volumn 10, Issue 1, 2014, Pages 473-478

  Wang, Ling ^a   Qian, Liyuan ^a   Li, Xiaorong ^a   Yan, Jin ^a  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

CARMA3; Colony fomation; Colorectal cancer; Invasion; microRNA 195; Proliferation

Indexed keywords

GELATINASE B; MICRORNA; MICRORNA 195; PROTEIN CARMA3; SCAFFOLD PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; CARD10 PROTEIN, HUMAN; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; MESSENGER RNA; MIRN195 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CELL INVASION; CELL PROLIFERATION; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; HT 29 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; CELL MOTION; CHEMISTRY; COLORECTAL TUMOR; GENETIC TRANSFECTION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; SEQUENCE ALIGNMENT; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; CARD SIGNALING ADAPTOR PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DOWN-REGULATION; HT29 CELLS; HUMANS; MICRORNAS; RNA, MESSENGER; SEQUENCE ALIGNMENT; TRANSFECTION; UP-REGULATION;

EID: 84901462601     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2178     Document Type: Article

References (27)

1. Boncheva V, Bonney SA, Brooks SE, et al: New targets for the immunotherapy of colon cancer-does reactive disease hold the answer? Cancer Gene Ther 20: 157-168, 2013.
2. Zhang N, Li X, Wu CW, et al: microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis. Oncogene 32: 5078-5088, 2012.
3. Yates LA, Norbury CJ and Gilbert RJ: The long and short of microRNA. Cell 153: 516-519, 2013.
4. Dassow H and Aigner A: MicroRNAs (miRNAs) in colorectal cancer: from aberrant expression towards therapy. Curr Pharm Des 19: 1242-1252, 2013.
5. Dong Y, Zhao J, Wu CW, et al: MiR-133a activates the p53/p21 pathway and functions as a tumor suppressor in colorectal cancer by repressing RFFL. Mol Cancer Res 11: 1051-1060, 2013.
6. Yu Y, Sarkar FH and Majumdar AP: Down-regulation of miR-21 induces differentiation of chemoresistant colon cancer cells and enhances susceptibility to therapeutic regimens. Transl Oncol 6: 180-186, 2013.
7. He JF, Luo YM, Wan XH and Jiang D: Biogenesis of MiRNA-195 and its role in biogenesis, the cell cycle, and apoptosis. J Biochem Mol Toxicol 25: 404-408, 2011.
8. Yang X, Yu J, Yin J, Xiang Q, Tang H and Lei X: MiR-195 regulates cell apoptosis of human hepatocellular carcinoma cells by targeting LATS2. Pharmazie 67: 645-651, 2012.
9. Mao JH, Zhou RP, Peng AF, et al: microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN. Oncol Lett 4: 1125-1129, 2012.
10. Ding J, Huang S, Wang Y, et al.: Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma. Hepatology 58: 654-666, 2013.
11. Yang G, Wu D, Zhu J, et al: Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1. Oncol Rep 30: 877-889, 2013.
12. Li Z, Qu L, Dong Q, et al: Overexpression of CARMA3 in non-small-cell lung cancer is linked for tumor progression. PLoS One 7: e36903, 2012.
13. Zhao T, Miao Z, Wang Z, et al: CARMA3 overexpression accelerates cell proliferation and inhibits paclitaxel-induced apoptosis through NF-κB regulation in breast cancer cells. Tumour Biol 34: 3041-3047, 2013.
14. Miao Z, Zhao T, Wang Z, et al: CARMA3 is overexpressed in colon cancer and regulates NF-κB activity and cyclin D1 expression. Biochem Biophys Res Commun 425: 781-787, 2012.
15. Feng X, Miao G, Han Y and Xu Y: CARMA3 is overexpressed in human glioma and promotes cell invasion through MMP9 regulation in A172 cell line. Tumour Biol: July 27, 2013 (Epub ahead of print).
16. Callegari E, Elamin BK, Sabbioni S, Gramantieri L and Negrini M: Role of microRNAs in hepatocellular carcinoma: a clinical perspective. Onco Targets Ther 6: 1167-1178, 2013.
17. Chou J, Shahi P and Werb Z: microRNA-mediated regulation of the tumor microenvironment. Cell Cycle 12: 3262-3271, 2013.
18. Bienertova-Vasku J, Sana J and Slaby O: The role of microRNAs in mitochondria in cancer. Cancer Lett 336: 1-7, 2013.
19. Hammoud SS, Cairns BR and Jones DA: Epigenetic regulation of colon cancer and intestinal stem cells. Curr Opin Cell Biol 25: 177-183, 2013.
20. Piepoli A, Tavano F, Copetti M, et al: Mirna expression profiles identify drivers in colorectal and pancreatic cancers. PLoS One 7: e33663, 2012.
21. Wang X, Wang J, Ma H, Zhang J and Zhou X: Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. Med Oncol 29: 919-927, 2012.
22. Liu L, Chen L, Xu Y, Li R and Du X: microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochem Biophys Res Commun 400: 236-240, 2010.
23. Qu J, Zhao L, Zhang P, et al: MicroRNA-195 chemosensitizes colon cancer cells to the chemotherapeutic drug doxorubicin by targeting the first binding site of BCL2L2 mRNA. J Cell Physiol: March 22, 2013 (Epub ahead of print).
24. Wu GL, Yuan JL, Huang XD, et al: Evaluating the expression of CARMA3 as a prognostic tumor marker in renal cell carcinoma. Tumour Biol 34: 3431-3435, 2013.
25. Rehman AO and Wang CY: CXCL12/SDF-1 alpha activates NF-kappaB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex. Int J Oral Sci 1: 105-118, 2009.
26. Sun J: CARMA3: A novel scaffold protein in regulation of NF-κB activation and diseases. World J Biol Chem 1: 353-361, 2010.
27. Dilly AK, Ekambaram P, Guo Y, et al: Platelet-type 12-lipoxygenase induces MMP9 expression and cellular invasion via activation of PI3K/Akt/NF-κB. Int J Cancer 133: 1784-1791, 2013.